Debra Hanna

A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis

Marjorie Z. Imperial, Payam Nahid, Patrick Phillips et al. · Nature Medicine · 2018 · 378 citations · Full text

Public Health, Pharmacotherapy, Clinical Pharmacology +16

A standardised method for interpreting the association between mutations and phenotypic drug resistance in<i>Mycobacterium tuberculosis</i>

Paolo Miotto, Belay Tessema, Elisa Tagliani et al. · European Respiratory Journal · 2017 · 333 citations · Full text

Life Sciences, Genetics, Microbiology +17

A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore

J. Richard Miller, Steve Dunham, Igor Mochalkin et al. · Proceedings of the National Academy of Sciences · 2009 · 160 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase

Matthew Ezewudo, Amanda Borens, Álvaro Chiner‐Oms et al. · Scientific Reports · 2018 · 101 citations · Full text

Life Sciences, Bioinformatics, Genetics +17

Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes

Tawanda Gumbo, Jotam G. Pasipanodya, Klaus Romero et al. · Clinical Infectious Diseases · 2015 · 91 citations

Pharmacy, Pharmacology, Evidence-based Practice +16